US Broker Ratings

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a Potential 1,833.70% Upside in the Biotechnology Sector

Heron Therapeutics, Inc. (NASDAQ: HRTX) might seem like just another name in the vast world of biotechnology, but recent data presents a compelling case for investors..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Navigating a 971% Potential Upside in Biotech

Gossamer Bio, Inc. (NASDAQ: GOSS), a prominent player in the biotechnology sector focused on treating pulmonary hypertension, presents a compelling yet complex investment opportunity. With a..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Unpacking the 332.91% Potential Upside

Investors eyeing the biotechnology sector may find Abeona Therapeutics Inc. (NASDAQ: ABEO) a compelling option given its striking potential upside of 332.91%. This commercial-stage biopharmaceutical company,..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating a 340.90% Revenue Surge in the Tech Sector

As the digital landscape continues to evolve, AMTD Digital Inc. (HKD) stands as a compelling player in the Technology sector, particularly within the Software – Application..

Nyxoah SA (NYXH)

⚠️ No article content returned.

..

Marti Technologies (MRT) Stock Analysis: Unveiling a Potential 184.75% Upside in Turkey’s Tech Sector

Marti Technologies, Inc. (NASDAQ: MRT) has emerged as a promising contender in the technology sector, specifically within the software application industry. Based in Turkey, this dynamic..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A Biotech with 139.80% Potential Upside

Candel Therapeutics, Inc. (CADL), a clinical-stage biopharmaceutical company, is capturing investor attention with its promising potential in the biotechnology sector. Headquartered in Needham, Massachusetts, and incorporated..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Navigating Growth with a 3.10% Upside Potential

Cytek Biosciences, Inc. (NASDAQ: CTKB), a healthcare sector player specializing in medical devices, offers intriguing prospects for investors focused on the cell analysis market. With a..

NRC Health (NRC) Stock Analysis: A Promising 27% Upside with Strong ROE and Dividend Yield

NRC Health (NASDAQ: NRC) is a notable player in the healthcare sector, specializing in health information services. With a robust market cap of $452.31 million, NRC..

Varex Imaging Corporation (VREX) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 2.77% Upside

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, specializes in the design and manufacture of X-ray imaging components. With a current market..

Cartesian Therapeutics (RNAC) Stock Analysis: A 431% Potential Upside in Biotech

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is garnering attention for its innovative approach in the biotechnology sector, particularly in the development of mRNA cell therapies targeting autoimmune..

Pacific Biosciences of California (PACB) Stock Analysis: Unpacking the 20.60% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the Healthcare sector’s Medical Devices industry, offers a compelling investment case for those interested in..

Senseonics Holdings, Inc. (SENS) Stock Analysis: 68.72% Potential Upside Sparks Investor Interest

For investors eyeing the healthcare sector, Senseonics Holdings, Inc. (SENS) presents a compelling opportunity with its innovative approach to glucose monitoring systems. This Maryland-based company, with..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 24% Potential Upside Amid Strong Buy Ratings

Alpha Teknova, Inc. (NASDAQ: TKNO) stands out in the healthcare sector, particularly within the drug manufacturers’ industry, as it continues to catch the eye of investors..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Potential Upside of 436.76% Beckons Investors

Investors with a keen eye on the biotechnology sector may find Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) an intriguing opportunity. This clinical-stage biopharmaceutical company, headquartered in the..

ExxonMobil Holdings (XOM) Stock Analysis: Navigating the Energy Giant’s 44% Revenue Growth

With a market capitalization of $727.85 billion, ExxonMobil Holdings Corporation (NYSE: XOM) remains a titan in the energy sector. As the largest publicly traded oil and..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 154% Potential Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a dynamic player in the healthcare sector, offers promising investment opportunities for those with an eye on the burgeoning medical device..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Exploring a 171.5% Potential Upside in the Biotech Sector

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands out as a promising player in the biotechnology sector, with a compelling narrative for investors keen on the healthcare landscape...

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Potential 114% Upside

In the dynamic and often unpredictable biotech sector, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands out with a fascinating blend of promise and challenge. With a..

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook on a Stock with a 52-Week High of $8.01

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector specializing in drug manufacturing for livestock and household animals, presents a complex profile for..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds